Alignment Healthcare, Inc. ALHC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 37.06% | 31.84% | 33.61% | 45.10% | 43.71% |
| Total Other Revenue | 0.20% | -0.85% | -2.90% | -4.68% | 26.17% |
| Total Revenue | 36.69% | 31.55% | 33.26% | 44.43% | 43.51% |
| Cost of Revenue | 40.27% | 30.95% | 32.87% | 44.85% | 41.50% |
| Gross Profit | 11.95% | 35.50% | 36.26% | 41.51% | 59.10% |
| SG&A Expenses | 24.58% | 26.21% | 16.67% | 24.30% | 21.07% |
| Depreciation & Amortization | 1.64% | 12.15% | 12.63% | 27.62% | 4.41% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.22% | 30.33% | 30.91% | 41.80% | 38.51% |
| Operating Income | -146.12% | 85.07% | 425.76% | 46.95% | 143.15% |
| Income Before Tax | -316.40% | 100.38% | 222.59% | 54.17% | 114.11% |
| Income Tax Expenses | -1,200.00% | -60.73% | 19.05% | -46,200.00% | 125.00% |
| Earnings from Continuing Operations | -315.93% | 133.57% | 222.04% | 64.57% | 114.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 100.00% | -- |
| Net Income | -315.93% | 133.36% | 225.26% | 64.60% | 114.12% |
| EBIT | -146.12% | 85.07% | 425.76% | 46.95% | 143.15% |
| EBITDA | -73.35% | 67.73% | 945.88% | 78.22% | 242.46% |
| EPS Basic | -306.42% | 123.04% | 218.05% | 66.17% | 113.55% |
| Normalized Basic EPS | -280.60% | 91.28% | 229.85% | 45.64% | 115.80% |
| EPS Diluted | -313.90% | 142.86% | 200.00% | 65.74% | 113.36% |
| Normalized Diluted EPS | -289.06% | 94.86% | 225.37% | 45.64% | 115.09% |
| Average Basic Shares Outstanding | 4.79% | 4.60% | 6.07% | 4.73% | 4.01% |
| Average Diluted Shares Outstanding | -0.18% | 2.63% | 10.08% | 4.73% | 9.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |